Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Systematic Review and Meta-Analysis on the Prognostic Value of BRCA Mutations, Homologous Recombination Gene Mutations, and Homologous Recombination Deficiencies in Cancer. | J Oncol | 2022 | 35909902 | PubTator, text mining | PubMed |
| Identification of new RAD51D-regulating microRNAs that also emerge as potent inhibitors of the Fanconi anemia/homologous recombination pathways. | Hum Mol Genet | 2022 | 35904444 | PubTator, text mining | PubMed |
| Permanent tissue damage in multiple sclerosis lesions is associated with reduced pre-lesion myelin and axon volume fractions. | Mult Scler | 2022 | 35903888 | PubTator, text mining | PubMed |
| Last but not least: BFL-1 as an emerging target for anti-cancer therapies. | Biochem Soc Trans | 2022 | 35900226 | PubTator, text mining | PubMed |
| The Role of HDACs in the Response of Cancer Cells to Cellular Stress and the Potential for Therapeutic Intervention. | Int J Mol Sci | 2022 | 35897717 | PubTator, text mining | PubMed |
| Identification of Tumor Antigens and Immune Subtypes of Malignant Mesothelioma for mRNA Vaccine Development. | Vaccines (Basel) | 2022 | 35893817 | PubTator, text mining | PubMed |
| High-Throughput CRISPR Screening in Hematological Neoplasms. | Cancers (Basel) | 2022 | 35892871 | PubTator, text mining | PubMed |
| Genetic Disorders with Predisposition to Paediatric Haematopoietic Malignancies-A Review. | Cancers (Basel) | 2022 | 35892827 | PubTator, text mining | PubMed |
| Gait Characterization and Analysis of Hereditary Amyloidosis Associated with Transthyretin Patients: A Case Series. | J Clin Med | 2022 | 35887731 | PubTator, text mining | PubMed |
| Tracking Clonal Evolution of Multiple Myeloma Using Targeted Next-Generation DNA Sequencing. | Biomedicines | 2022 | 35884979 | PubTator, text mining | PubMed |
| A New Multi-Color FISH Assay for Brush Biopsy-Based Detection of Chromosomal Aneuploidy in Oral (Pre)Cancer in Patients with Fanconi Anemia. | Cancers (Basel) | 2022 | 35884529 | PubTator, text mining | PubMed |
| Antioxidant Activity Evaluation and Assessment of the Binding Affinity to HSA of a New Catechol Hydrazinyl-Thiazole Derivative. | Antioxidants (Basel) | 2022 | 35883736 | PubTator, text mining | PubMed |
| Analysis of Alternative mRNA Splicing in Vemurafenib-Resistant Melanoma Cells. | Biomolecules | 2022 | 35883549 | PubTator, text mining | PubMed |
| The APE2 Exonuclease Is a Client of the Hsp70-Hsp90 Axis in Yeast and Mammalian Cells. | Biomolecules | 2022 | 35883419 | PubTator, text mining | PubMed |
| Somatic mutation analysis of Mesonephric-Like adenocarcinoma and associated putative precursor Lesions: Insight into pathogenesis and potential molecular treatment targets. | Gynecol Oncol Rep | 2022 | 35880223 | PubTator, text mining | PubMed |
| Emerging Biomarker-Guided Therapies in Prostate Cancer. | Curr Oncol | 2022 | 35877260 | PubTator, text mining | PubMed |
| Application of Multi-Omics Approach in Sarcomas: A Tool for Studying Mechanism, Biomarkers, and Therapeutic Targets. | Front Oncol | 2022 | 35875106 | PubTator, text mining | PubMed |
| Emerging Roles of Non-proteolytic Ubiquitination in Tumorigenesis. | Front Cell Dev Biol | 2022 | 35874839 | PubTator, text mining | PubMed |
| IL22RA1/JAK/STAT Signaling Acts As a Cancer Target Through Pan-Cancer Analysis. | Front Immunol | 2022 | 35874683 | PubTator, text mining | PubMed |
| Shared Genetic Risk Factors Between Cancer and Cardiovascular Diseases. | Front Cardiovasc Med | 2022 | 35872888 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=42